NCT03791723 (APART-AF) is a NA clinical trial of Sacubitril-Valsartan in Atrial Fibrillation, sponsored by The Second Affiliated Hospital of Chongqing Medical University.

Who is sponsoring NCT03791723?

NCT03791723 is sponsored by The Second Affiliated Hospital of Chongqing Medical University.

What drugs are being tested in NCT03791723?

Interventions in NCT03791723: Sacubitril-Valsartan, Valsartan.

What condition does NCT03791723 study?

NCT03791723 studies Atrial Fibrillation, Cardiac Remodeling, Atrial, Sacubitril/Valsartan.

Is NCT03791723 still recruiting?

NCT03791723 is currently status unknown. Last updated 19 March 2019.

Last reviewed 2019-03-19 · How we verify

NCT03791723: APART-AF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of ARNI in Patients With Persistent AF and Enlarged Left Atrium After Catheter Ablation

Status unknown NA Last updated 19 March 2019

What this trial tests

NA trial testing Sacubitril-Valsartan in Atrial Fibrillation in 90 participants. Status unknown.

Timeline

1 June 2019

Primary endpoint
1 January 2021

30 December 2021

Quick facts

Lead sponsor	The Second Affiliated Hospital of Chongqing Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	90
Start date	1 June 2019
Primary completion	1 January 2021
Estimated completion	30 December 2021

Drugs / interventions tested

Sacubitril-Valsartan — full drug profile →
Valsartan (VALSARTAN) — full drug profile →

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →
Cardiac Remodeling, Atrial — all drugs for Cardiac Remodeling, Atrial →
Sacubitril/Valsartan — all drugs for Sacubitril/Valsartan →

Sponsor

The Second Affiliated Hospital of Chongqing Medical University

Who can join

Adults 18 to 80, any sex, with Atrial Fibrillation or Cardiac Remodeling, Atrial. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this clinical randomized trial is to evaluate the efficacy and safety of Sacubitril/Valsartan compared with ARB in improving cardiac remodeling in patients With Enlarged Left Atrium Diameter and Persistent AF.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sacubitril-Valsartan

Trials testing the same drug.

NCT04637152 — Sacubitril/Valsartan in Resistant Hypertension · Phase 2 · completed
NCT04498780 — Hemodynamic Effects of ARNI on Noninvasive Pressure-volume Analysis in Patients With Chronic Heart Failure · completed
NCT04575675 — Dapagliflozin on Hypotensive Heart Failure Patients After Sacubitril/Valsartan Therapy · Phase 4 · completed
NCT04128891 — Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in Heart Failure With Preserved Ejection Fraction · Phase 3 · withdrawn
NCT04688294 — The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure · Phase 4 · completed

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other The Second Affiliated Hospital of Chongqing Medical University trials

Trials by the same sponsor.

NCT07534046 — Impact of Metabolic Disorders on cACLD Outcomes · not yet recruiting
NCT07465003 — Cohort Study of Chronic Liver Disease Complicated by Sepsis · not yet recruiting
NCT07339644 — Functional Lung Avoidance Radiotherapy Guided by 4DCT Pulmonary Ventilation Function Imaging: A Prospective Single-arm C · NA · recruiting
NCT07048782 — Development and Validation of a Risk Prediction Model for Postoperative Visceral Pain in Abdominal Surgery Patients · not yet recruiting
NCT07033949 — Effect of Green Light Exposure at Different Times on the Pain of Subjects · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03791723 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Second Affiliated Hospital of Chongqing Medical University
Last refreshed: 19 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03791723.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing